News
The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm.
News
The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm.
Press release
Some of Scotland’s brightest business prospects are preparing for an exciting future after being crowned winners of a major Scottish competition.
Press release
Two University of Dundee initiatives are to benefit from millions of pounds of UK Government investment.
Press release
The University of Dundee has been named the best seat of learning in Scotland for supporting spinout businesses, according to new rankings
Press release
World-leading and collaborative research undertaken at the University of Dundee has been honoured at one of the Life Sciences sector’s most prestigious award ceremonies.
Press release
Three spinout projects from the University of Dundee with the potential to deliver significant healthcare benefits have received more than £250,000 from Scottish Enterprise to support their development.
Press release
A project to grow the Tay Cities BioMedical cluster of world-class life sciences companies will generate hundreds of millions of pounds for the local economy.
Press release
The University of Dundee is leading an international collaboration with the intention of developing the first vaccine for Strep A.
Press release
An entrepreneurial scientist from the University of Dundee has proven his business concept is more than skin deep after winning one of the country’s top enterprise awards
Press release
University of Dundee spinout company Tay Therapeutics has announced a licensing deal potentially worth over $50 million in upfront and milestone payments, plus royalties.
Press release
The University of Dundee has welcomed the signing of the Tay Cities Deal, which will boost efforts to capitalise on our world-class strengths in biomedicine and forensic science, creating hundreds of new jobs and attracting further investment.
Press release
Cancer Research UK-funded scientists in Dundee have discovered how some cancer drugs can target the disease while sparing healthy tissue.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Feature
Almost twenty years after deciphering the human genome, our understanding of human disease is still far from complete.
Press release
The University of Dundee has been named the UK’s best for supporting spinout businesses, according to industry-leading analysis.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Press release
The Biochemical Society have given their annual Industry and Academic Collaboration Award to Professor Gopal Sapkota, of the University of Dundee
Press release
The University of Dundee is to partner with global biopharmaceutical company Almirall to develop new treatments for severe skin diseases with high level of unmet medical need.
Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
A University of Dundee-led programme that will train the next generation of barley researchers has received a multi-million pound investment.